advertisement

---

Yang J 15

Showing records 1 to 15 | Display all abstracts from Yang J

98894 HL3501, a Novel Selective A3 Adenosine Receptor Antagonist, Lowers Intraocular Pressure (IOP) in Animal Glaucoma Models
Kim Y
Translational vision science & technology 2022; 11: 30

---

98424 Construction and analysis of mRNA, lncRNA, and transcription factor regulatory networks after retinal ganglion cell injury
Yang N
Experimental Eye Research 2022; 215: 108915

---

98358 Advances in biomedical study of the myopia-related signaling pathways and mechanisms
Yang J; Ouyang X
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2022; 145: 112472

---

98424 Construction and analysis of mRNA, lncRNA, and transcription factor regulatory networks after retinal ganglion cell injury
Yang J
Experimental Eye Research 2022; 215: 108915

---

98894 HL3501, a Novel Selective A3 Adenosine Receptor Antagonist, Lowers Intraocular Pressure (IOP) in Animal Glaucoma Models
Yang J
Translational vision science & technology 2022; 11: 30

---

98358 Advances in biomedical study of the myopia-related signaling pathways and mechanisms
Fu H
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2022; 145: 112472

---

98424 Construction and analysis of mRNA, lncRNA, and transcription factor regulatory networks after retinal ganglion cell injury
He X
Experimental Eye Research 2022; 215: 108915

---

98894 HL3501, a Novel Selective A3 Adenosine Receptor Antagonist, Lowers Intraocular Pressure (IOP) in Animal Glaucoma Models
Kim JY
Translational vision science & technology 2022; 11: 30

---

98358 Advances in biomedical study of the myopia-related signaling pathways and mechanisms
Hou X
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2022; 145: 112472

---

98894 HL3501, a Novel Selective A3 Adenosine Receptor Antagonist, Lowers Intraocular Pressure (IOP) in Animal Glaucoma Models
Lee JM
Translational vision science & technology 2022; 11: 30

---

98424 Construction and analysis of mRNA, lncRNA, and transcription factor regulatory networks after retinal ganglion cell injury
Zhang W
Experimental Eye Research 2022; 215: 108915

---

98358 Advances in biomedical study of the myopia-related signaling pathways and mechanisms
Liu Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2022; 145: 112472

---

98424 Construction and analysis of mRNA, lncRNA, and transcription factor regulatory networks after retinal ganglion cell injury
Xing Y
Experimental Eye Research 2022; 215: 108915

---

98894 HL3501, a Novel Selective A3 Adenosine Receptor Antagonist, Lowers Intraocular Pressure (IOP) in Animal Glaucoma Models
Son WC; Moon BG
Translational vision science & technology 2022; 11: 30

---

98358 Advances in biomedical study of the myopia-related signaling pathways and mechanisms
Xie Y; Yu H; Wang G
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2022; 145: 112472

---